• 2022
  Stéphane Bretagne, Karine Sitbon, Marie Desnos-Ollivier, Dea Garcia-Hermoso, Valérie Letscher-Bru, Sophie Cassaing, Laurence Millon, Florent Morio, Jean-Pierre Gangneux, Lilia Hasseine, Loïc Favennec, Estelle Cateau, Eric Bailly, Maxime Moniot, Julie Bonhomme, Nicole Desbois-Nogard, Taieb Chouaki, André Paugam, Bernard Bouteille, Marc Pihet, Frédéric Dalle, Odile Eloy, Milène Sasso, Magalie Demar, Patricia Mariani-Kurkdjian, Vincent Robert, Olivier Lortholary, Françoise Dromer, The French Mycoses Study Group, Céline Damiani, Hervé Dupont, Julien Maizel, Anne Totet, Jean-Philippe Bouchara, Anne Pauline Bellanger, Ana Berceanu, Jean Christophe Navellou, Emeline Scherer, Philippe Abboud, Christine Aznar, Denis Blanchet, Félix Djossou, Sophie Cayot, Cyril Garrouste, Olivier Lesens, Cécile Moluçon, Céline Nourrisson, Philippe Poirier, Éloïse Bailly, Louise Basmaciyan, Bouhemad Belaid, Mathieu Blot, Denis Caillot, Pierre-Emmanuel Charles, Jean Pierre Quenot, Emmanuelle Amazan, Emilie Baubion, André Cabie, Cyrille Chabartier, Christophe Deligny, Violaine Emal, Olivier Flechelle, Yves Hatchuel, Yohann Le Govic, Harold Merle, Charline Miossec, Jean-Marie Turmel, Ruddy Valentino, Marie-Fleur Durieux, Pascal Turlure, Victor Mercier, Martine Gari-Toussaint, Karine Risso, Loïc Simon, Cedric Bretonnière, David Boutoille, Thomas Gastinne, Karim Lakhal, Elise Launay, Thierry Lepoivre, Pierre Peterlin, Fanny Rialland, Patrice Le Pape, Etienne Canoui, Naima Dahane, Solène Kerneis, Cécile Angebault, Marie-Elisabethh Bougnoux, Nadia Guennouni, Fanny Lanternier, Bennedicte Neven, Mehdi Oualha, Anne Scemla, Emilie Sitterlé, Felipe Suarez, Julie Toubiana, Stéphane Bonacorci, Alexandre Alanio, Anne Bergeron, Blandine Denis, Maud Gits-Muselli, Samia Hamane, Sophie Touratier, Christine Chaumeil, Lilia Merabet, Joelle Claudéon, Elodie Curlier, Valérie Galantine, Jean Claude Gallois, Samuel Markowicz, Muriel Nicolas, Pascal Musson, Kinda Schepers, Alida Minoza, Catherine Kauffmann-Lacroix, Hélène Guégan, Damien Costa, Marion Dehais, Gilles Gargala, Odile Bajolet, Firouze Banisadr, Joel Cousson, Chantal Himberlin, Antoine Huguenin, Dominique Toubas, Pierre Flori, Caroline Mahinc, Hélène Raberin, Julie Denis, Raoul Herbrecht, Paul-Michel Mertes, Fehrat Meziani, Marcela Sabou, Francis Schneider, Anne-Isabelle Bertozzi, Pamela Chauvin, Elena Charpentier, Olivier Cointault, Claire Cottrel, Karen Delavigne, Stanislas Faguer, Judith Fillaux, Emilie Guemas, Xavier Iriart, Lucie Lelièvre, Jean Ruiz, Frédéric Bastides, Adélaïde Chesnay, Guillaume Desoubeaux, Audrey Therby, Elisabeth Chachaty, Bertrand Gachot, Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018), mBio, 2022, 13 (3), pp.e0092022. ⟨10.1128/mbio.00920-22⟩.
• 2022
  Desnos-Ollivier M, Bretagne S, Lortholary O, Dromer F, , , Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations., Antimicrob Agents Chemother 2022 May; 66(5): e0172521.
• 2021
  Bretagne S, Sitbon K, Botterel F, Dellière S, Letscher-Bru V, Chouaki T, Bellanger AP, Bonnal C, Fekkar A, Persat F, Costa D, Bourgeois N, Dalle F, Lussac-Sorton F, Paugam A, Cassaing S, Hasseine L, Huguenin A, Guennouni N, Mazars E, Le Gal S, Sasso M, Brun S, Cadot L, Cassagne C, Cateau E, Gangneux JP, Moniot M, Roux AL, Tournus C, Desbois-Nogard N, Le Coustumier A, Moquet O, Alanio A, Dromer F, , , COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave., Microbiol Spectr 2021 Oct; (): e0113821.
• 2021
  Desnos-Ollivier M, Lortholary O, Bretagne S, Dromer F, , Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species., Antimicrob Agents Chemother 2021 May; 65(6): .
• 2021
  Alanio A, Gits-Muselli M, Lanternier F, Sturny-Leclère A, Benazra M, Hamane S, Rodrigues AM, Garcia-Hermoso D, Lortholary O, Dromer F, Bretagne S, , , Evaluation of a New Histoplasma spp. Quantitative RT-PCR Assay., J Mol Diagn 2021 Mar; (): .
• 2021
  Bretagne S, Desnos-Ollivier M, Sitbon K, Lortholary O, Che D, Dromer F, , , No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004-2017, Paris, France)., Front Med (Lausanne) 2021 ; 8(): 641965.
• 2020
  Bronnimann D, Garcia-Hermoso D, Dromer F, Lanternier F, , , , Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification., Med Mycol 2021 May; 59(5): 486-497.
• 2020
  Desnos-Ollivier M, Maufrais C, Pihet M, Aznar C, Dromer F, , , Epidemiological investigation for grouped cases of Trichosporon asahii using whole genome and IGS1 sequencing., Mycoses 2020 Sep; 63(9): 942-951.
• 2020
  Menu E, Criscuolo A, Desnos-Ollivier M, Cassagne C, D'Incan E, Furst S, Ranque S, Berger P, Dromer F, , Saprochaete clavata Outbreak Infecting Cancer Center through Dishwasher., Emerg Infect Dis 2020 Sep; 26(9): 2031-2038.
• 2020
  Garcia-Hermoso D, Hamane S, Fekkar A, Jabet A, Denis B, Siguier M, Galeazzi G, Haddad E, Brun S, Vidal V, Nevez G, Le Berre R, Gits-Muselli M, Lanternier F, Bretagne S, , Invasive Infections with Nannizziopsis obscura Species Complex in 9 Patients from West Africa, France, 2004-20201., Emerg Infect Dis 2020 09; 26(9): .
• 2020
  Nyuykonge B, Klaassen CHW, Zandijk WHA, de Hoog GS, Ahmed SA, Desnos-Ollivier M, Verbon A, Bonifaz A, van de Sande WWJ, , Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico., J Eur Acad Dermatol Venereol 2020 Aug; 34(8): 1828-1834.
• 2020
  Mercier V, Bastides F, Bailly É, Garcia-Hermoso D, Miquelestorena-Standley E, El Baz Z, Marteau E, Vermes E, De Muret A, Bernard L, Desoubeaux G, , Successful Terbinafine Treatment for Cutaneous Phaeohyphomycosis Caused by Trematosphaeria grisea in a Heart Transplanted Man: Case Report and Literature Review., Mycopathologia 2020 Aug; 185(4): 709-716.
• 2020
  Desnos-Ollivier M, Letscher-Bru V, Neuvéglise C, Dromer F, , Yarrowia lipolytica causes sporadic cases and local outbreaks of infections and colonisation., Mycoses 2020 Jul; 63(7): 737-745.
• 2020
  Ahmed EA, Nour BYM, Abakar AD, Hamid S, Mohamadani AA, Daffalla M, Mahmoud M, Altayb HN, Desnos-Ollivier M, de Hoog S, Ahmed SA, , The genus Madurella: Molecular identification and epidemiology in Sudan., PLoS Negl Trop Dis 2020 Jul; 14(7): e0008420.
• 2020
  Danion F, Duréault A, Gautier C, Senechal A, Persat F, Bougnoux ME, Givel C, Couderc LJ, Lortholary O, Garcia-Hermoso D, Lanternier F, , Emergence of azole resistant-Aspergillus fumigatus infections during STAT3-deficiency., J Med Microbiol 2020 Jun; 69(6): 844-849.
• 2020
  Chow NA, Muñoz JF, Gade L, Berkow EL, Li X, Welsh RM, Forsberg K, Lockhart SR, Adam R, Alanio A, Alastruey-Izquierdo A, Althawadi S, Araúz AB, Ben-Ami R, Bharat A, Calvo B, Desnos-Ollivier M, Escandón P, Gardam D, Gunturu R, Heath CH, Kurzai O, Martin R, Litvintseva AP, Cuomo CA, , Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses., mBio 2020 Apr; 11(2): .
• 2020
  Plachouras D, Lötsch F, Kohlenberg A, Monnet DL, , , Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019., Euro Surveill 2020 03; 25(12): .
• 2020
  Dellière S, Rivero-Menendez O, Gautier C, Garcia-Hermoso D, Alastruey-Izquierdo A, Alanio A, , Emerging mould infections: Get prepared to meet unexpected fungi in your patient., Med Mycol 2020 02; 58(2): e2.
• 2019
  Hommel B, Sturny-Leclère A, Volant S, Veluppillai N, Duchateau M, Yu CH, Hourdel V, Varet H, Matondo M, Perfect JR, Casadevall A, Dromer F, Alanio A, Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype., PLoS Pathog 2019 Jul; 15(7): e1007945.
• 2019
  Desnos-Ollivier M, Bretagne S, Boullié A, Gautier C, Dromer F, Lortholary O, , , Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017)., Clin Microbiol Infect 2019 May; 25(5): 634.e1-634.e4.
• 2019
  Garcia-Hermoso D, Valenzuela-Lopez N, Rivero-Menendez O, Alastruey-Izquierdo A, Guarro J, Cano-Lira JF, Stchigel AM, , , Diversity of coelomycetous fungi in human infections: A 10-y experience of two European reference centres., Fungal Biol 2019 04; 123(4): 341-349.
• 2019
  Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, , Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial., Trials 2019 01; 20(1): 48.
• 2019
  Hoang MTV, Irinyi L, Chen SCA, Sorrell TC, , Meyer W, , Dual DNA Barcoding for the Molecular Identification of the Agents of Invasive Fungal Infections., Front Microbiol 2019 ; 10(): 1647.
• 2018
  Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, , AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial., Trials 2018 Nov; 19(1): 649.
• 2018
  Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS, Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries, Lancet Infect Dis 2019 Apr;19(4):e143-e147.
• 2018
  Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN, Dromer F, Harrison T, Cohen JF, Lortholary O, Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis, Clin. Infect. Dis. 2019 Feb;68(4):688-698.
• 2018
  Hommel B, Mukaremera L, Cordero RJB, Coelho C, Desjardins CA, Sturny-Leclère A, Janbon G, Perfect JR, Fraser JA, Casadevall A, Cuomo CA, Dromer F, Nielsen K, Alanio A, , Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators., PLoS Pathog 2018 05; 14(5): e1006982.
• 2018
  Garcia-Hermoso D, Criscuolo A, Lee SC, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Schaal JV, Mimoun M, Mebazaa A, Heitman J, Dromer F, Brisse S, Bretagne S, Alanio A, , Outbreak of Invasive Wound Mucormycosis in a Burn Unit Due to Multiple Strains of Mucor circinelloides f. circinelloides Resolved by Whole-Genome Sequencing., mBio 2018 04; 9(2): .
• 2018
  Desnos-Ollivier M, Bórmida V, Poirier P, Nourrisson C, Pan D, Bretagne S, Puime A, Dromer F, , , , Population Structure of Candida parapsilosis: No Genetic Difference Between French and Uruguayan Isolates Using Microsatellite Length Polymorphism., Mycopathologia 2018 Apr; 183(2): 381-390.
• 2018
  Temfack E, Kouanfack C, Mossiang L, Loyse A, Fonkoua MC, Molloy SF, Koulla-Shiro S, Delaporte E, Dromer F, Harrison T, Lortholary O, Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test, Front Microbiol 2018;9:409.
• 2018
  Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D, , epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017, Euro Surveill. 2018 03;23(13).
• 2018
  Kilens S, Meistermann D, Moreno D, Chariau C, Gaignerie A, Reignier A, Lelièvre Y, Casanova M, Vallot C, Nedellec S, Flippe L, Firmin J, Song J, Charpentier E, Lammers J, Donnart A, Marec N, Deb W, Bihouée A, Le Caignec C, Pecqueur C, Redon R, Barrière P, Bourdon J, Pasque V, Soumillon M, Mikkelsen TS, Rougeulle C, Fréour T, David L, , , Parallel derivation of isogenic human primed and naive induced pluripotent stem cells., Nat Commun 2018 Jan; 9(1): 360.
• 2018
  Piasecka B, Duffy D, Urrutia A, Quach H, Patin E, Posseme C, Bergstedt J, Charbit B, Rouilly V, MacPherson CR, Hasan M, Albaud B, Gentien D, Fellay J, Albert ML, Quintana-Murci L, , , Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges., Proc Natl Acad Sci U S A 2018 Jan; 115(3): E488-E497.
• 2017
  Cogliati M, Puccianti E, Montagna MT, De Donno A, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Trovato L, Dipineto L, Rickerts V, Akcaglar S, Mlinaric-Missoni E, Bertout S, Vencà ACF, Sampaio AC, Criseo G, Ranque S, Çerikçioğlu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Boekhout T, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Colom MF, , Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe., Environ Microbiol 2017 Oct; 19(10): 4318-4325.
• 2017
  Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A, Cryptococcal meningitis: A neglected NTD?, PLoS Negl Trop Dis 2017 Jun;11(6):e0005575.
• 2017
  Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F, , , Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)., J Antimicrob Chemother 2017 Jun; 72(6): 1784-1793.
• 2017
  Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F, , , The risk and clinical outcome of candidemia depending on underlying malignancy., Intensive Care Med 2017 May; 43(5): 652-662.
• 2017
  Kwon-Chung KJ, Bennett JE, Wickes BL, Meyer W, Cuomo CA, Wollenburg KR, Bicanic TA, Castañeda E, Chang YC, Chen J, Cogliati M, Dromer F, Ellis D, Filler SG, Fisher MC, Harrison TS, Holland SM, Kohno S, Kronstad JW, Lazera M, Levitz SM, Lionakis MS, May RC, Ngamskulrongroj P, Pappas PG, Perfect JR, Rickerts V, Sorrell TC, Walsh TJ, Williamson PR, Xu J, Zelazny AM, Casadevall A, The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis, mSphere 2017 Jan-Feb;2(1).
• 2016
  Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Oliveri S, Trovato L, Dipineto L, Rickerts V, McCormick-Smith I, Akcaglar S, Tore O, Mlinaric-Missoni E, Bertout S, Mallié M, Martins MD, Vencà AC, Vieira ML, Sampaio AC, Pereira C, Criseo G, Romeo O, Ranque S, Al-Yasiri MH, Kaya M, Cerikcioglu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Korem M, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Theelen B, Boekhout T, Lockhart SR, Tintelnot K, Tortorano AM, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Alonso B, Colom MF, , Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin., FEMS Yeast Res 2016 Nov; 16(7): .
• 2016
  Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, Lortholary O,, Ten-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in France, Open Forum Infect Dis 2016 Apr;3(2):ofw106.
• 2016
  Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C, Velegraki A, Ellabib MS, Nardoni S, Macci C, Oliveri S, Trovato L, Dipineto L, Rickerts V, McCormick-Smith I, Akcaglar S, Tore O, Mlinaric-Missoni E, Bertout S, Mallié M, Martins Mda L, Vencà AC, Vieira ML, Sampaio AC, Pereira C, Criseo G, Romeo O, Ranque S, Al-Yasiri MH, Kaya M, Cerikcioglu N, Marchese A, Vezzulli L, Ilkit M, Desnos-Ollivier M, Pasquale V, Korem M, Polacheck I, Scopa A, Meyer W, Ferreira-Paim K, Hagen F, Theelen B, Boekhout T, Lockhart SR, Tintelnot K, Tortorano AM, Dromer F, Varma A, Kwon-Chung KJ, Inácio J, Alonso B, Colom MF, , Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin., FEMS Yeast Res 2016 Jun; 16(4): .
• 2016
  Alanio A, Gits-Muselli M, Mercier-Delarue S, Dromer F, Bretagne S, , Diversity of Pneumocystis jirovecii during Infection Revealed by Ultra-Deep Pyrosequencing., Front Microbiol 2016 ; 7(): 733.
• 2015
  Alanio A, Garcia-Hermoso D, Criscuolo A, Legrand M, Chaouat M, Denis B, Lafaurie M, Rouveau M, Soler C, Mimoun M, Mebazaa A, Dromer F, Brisse S, Bretagne S, Whole genome sequencing to investigate an outbreak of mucormycosis in a burn unit, Mycoses 2015 Oct;58(S4):23-23.
• 2015
  Rammaert B, Jouvion G, de Chaumont F, Garcia-Hermoso D, Szczepaniak C, Renaudat C, Olivo-Marin JC, Chrétien F, Dromer F, Bretagne S, , Absence of Fungal Spore Internalization by Bronchial Epithelium in Mouse Models Evidenced by a New Bioimaging Approach and Transmission Electronic Microscopy., Am J Pathol 2015 Sep; 185(9): 2421-30.
• 2015
  Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O,, Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis, J. Antimicrob. Chemother. 2015 Nov;70(11):3116-23.
• 2015
  Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, , , Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation., mBio 2015 Jun; 6(3): e00311.
• 2015
  Alanio A, Vernel-Pauillac F, Sturny-Leclère A, Dromer F, Cryptococcus neoformans host adaptation: toward biological evidence of dormancy, MBio 2015;6(2).
• 2014
  Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F, Population-based analysis of invasive fungal infections, France, 2001-2010, Emerging Infect. Dis. 2014 Jul;20(7):1149-55.
• 2014
  Desnos-Ollivier M, Blanc C, Garcia-Hermoso D, Hoinard D, Alanio A, Dromer F, , Misidentification of Saprochaete clavata as Magnusiomyces capitatus in clinical isolates: utility of internal transcribed spacer sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry and importance of reliable databases., J Clin Microbiol 2014 Jun; 52(6): 2196-8.
• 2013
  Loyse A, Dromer F, Day J, Lortholary O, Harrison TS, Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal, J. Antimicrob. Chemother. 2013 Nov;68(11):2435-44.
• 2012
  Bitar D, Morizot G, Van Cauteren D, Dannaoui E, Lanternier F, Lortholary O, Dromer F, Estimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative data, Rev Epidemiol Sante Publique 2012 Oct;60(5):383-7.
• 2012
  Salas V, Pastor FJ, Calvo E, Sutton D, García-Hermoso D, Mayayo E, Dromer F, Fothergill A, Alvarez E, Guarro J, Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole, Med. Mycol. 2012 Oct;50(7):710-5.
• 2012
  Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O,, A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007), Clin. Infect. Dis. 2012 Feb;54 Suppl 1:S35-43.
• 2012
  Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O, , , Candida spp. with acquired echinocandin resistance, France, 2004-2010., Emerg Infect Dis 2012 Jan; 18(1): 86-90.
• 2011
  Peigne V, Dromer F, Elie C, Lidove O, Lortholary O,, Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras, Am. J. Trop. Med. Hyg. 2011 Nov;85(5):934-41.
• 2011
  Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D, , , Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France., Antimicrob Agents Chemother 2011 Nov; 55(11): 5358-61.
• 2011
  Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, Coignard B, Dromer F, Bretagne S,, Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007), Clin. Microbiol. Infect. 2011 Dec;17(12):1882-9.
• 2010
  Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, , Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients, Clin. Infect. Dis. 2010 Nov;51(9):1062-9.
• 2010
  Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J, Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea, J. Clin. Microbiol. 2010 Dec;48(12):4410-6.
• 2010
  Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff SL, House AA, Houston SH, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, , Cutaneous cryptococcosis in solid organ transplant recipients, Med. Mycol. 2010 Sep;48(6):785-91.
• 2010
  Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K, Cryptococcal cell morphology affects host cell interactions and pathogenicity, PLoS Pathog. 2010;6(6):e1000953.
• 2010
  Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC, Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america, Clin. Infect. Dis. 2010 Feb;50(3):291-322.
• 2010
  Costa JM, Garcia-Hermoso D, Olivi M, Cabaret O, Farrugia C, Lecellier G, Dromer F, Bretagne S, Genotyping of Candida albicans using length fragment and high-resolution melting analyses together with minisequencing of a polymorphic microsatellite locus, J. Microbiol. Methods 2010 Mar;80(3):306-9.
• 2010
  Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, Del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Muñoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Fisher RA, Husain S, Wagener MM, Singh N, Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis, Transplantation 2010 Jan;89(1):69-74.
• 2009
  Scott-Algara D, Balabanian K, Chakrabarti LA, Mouthon L, Dromer F, Didier C, Arenzana-Seisdedos F, Lortholary O, Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4, Blood 2010 May;115(18):3708-17.
• 2009
  Brugière O, Forget E, Biondi G, Métivier AC, Mal H, Dauriat G, Faussart A, Dupont B, Lortholary O, Dromer F, Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France, Transplantation 2009 Dec;88(11):1319-20.
• 2009
  Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, Somani J, Gupta KL, del Busto R, Pruett TL, Sifri CD, Limaye AP, John GT, Klintmalm GB, Pursell K, Stosor V, Morris MI, Dowdy LA, Munoz P, Kalil AC, Garcia-Diaz J, Orloff S, House AA, Houston S, Wray D, Huprikar S, Johnson LB, Humar A, Razonable RR, Husain S, Singh N, Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis, Clin. Infect. Dis. 2009 Dec;49(11):1721-8.
• 2009
  Dannaoui E, Paugam A, Develoux M, Chochillon C, Matheron J, Datry A, Bouges-Michel C, Bonnal C, Dromer F, Bretagne S, Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories, Clin. Microbiol. Infect. 2010 Jul;16(7):863-9.
• 2009
  Garcia-Hermoso D, Hoinard D, Gantier JC, Grenouillet F, Dromer F, Dannaoui E, Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa, J. Clin. Microbiol. 2009 Dec;47(12):3862-70.
• 2009
  Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O, Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006, Emerging Infect. Dis. 2009 Sep;15(9):1395-401.
• 2008
  Jarvis JN, Dromer F, Harrison TS, Lortholary O, Managing cryptococcosis in the immunocompromised host, Curr. Opin. Infect. Dis. 2008 Dec;21(6):596-603.
• 2008
  Singh N, Dromer F, Perfect JR, Lortholary O, Cryptococcosis in solid organ transplant recipients: current state of the science, Clin. Infect. Dis. 2008 Nov;47(10):1321-7.
• 2008
  Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F, Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans, Infect. Immun. 2009 Jan;77(1):120-7.
• 2008
  Singh N, Lortholary O, Dromer F, Alexander BD, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S, , Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings, Transplantation 2008 Sep;86(5):647-51.
• 2008
  Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E, , , Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing., Antimicrob Agents Chemother 2008 Sep; 52(9): 3092-8.
• 2008
  Bovers M, Hagen F, Kuramae EE, Hoogveld HL, Dromer F, St-Germain G, Boekhout T, AIDS patient death caused by novel Cryptococcus neoformans x C. gattii hybrid, Emerging Infect. Dis. 2008 Jul;14(7):1105-8.
• 2008
  Charlier C, Dromer F, Lévêque C, Chartier L, Cordoliani YS, Fontanet A, Launay O, Lortholary O, , Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era, PLoS ONE 2008;3(4):e1950.
• 2008
  Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Muñoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S, Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen, Clin. Infect. Dis. 2008 Jan;46(2):e12-8.
• 2008
  , EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts, Clin. Microbiol. Infect. 2008 Apr;14(4):398-405.
• 2007
  Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, Del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Albert ND, Wagener MM, Singh N, Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis, Antimicrob. Agents Chemother. 2008 Feb;52(2):735-8.
• 2007
  Dannaoui E, Lortholary O, Raoux D, Bougnoux ME, Galeazzi G, Lawrence C, Moissenet D, Poilane I, Hoinard D, Dromer F, , Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006, Antimicrob. Agents Chemother. 2008 Feb;52(2):778-81.
• 2007
  Garcia-Hermoso D, Cabaret O, Lecellier G, Desnos-Ollivier M, Hoinard D, Raoux D, Costa JM, Dromer F, Bretagne S, , Comparison of microsatellite length polymorphism and multilocus sequence typing for DNA-Based typing of Candida albicans., J Clin Microbiol 2007 Dec; 45(12): 3958-63.
• 2007
  Ranque S, Pelletier R, Michel-Nguyen A, Dromer F, Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis, Eur. J. Clin. Microbiol. Infect. Dis. 2007 Dec;26(12):941-3.
• 2007
  Loulergue P, Bastides F, Baudouin V, Chandenier J, Mariani-Kurkdjian P, Dupont B, Viard JP, Dromer F, Lortholary O, Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients, Emerging Infect. Dis. 2007 Nov;13(11):1647-52.
• 2007
  Micol R, Lortholary O, Sar B, Laureillard D, Ngeth C, Dousset JP, Chanroeun H, Ferradini L, Guerin PJ, Dromer F, Fontanet A, Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients, J. Acquir. Immune Defic. Syndr. 2007 Aug;45(5):555-9.
• 2007
  Lortholary O, Dannaoui E, Raoux D, Hoinard D, Datry A, Paugam A, Poirot JL, Lacroix C, Dromer F, , In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing, Antimicrob. Agents Chemother. 2007 Sep;51(9):3378-80.
• 2007
  Schwarz P, Lortholary O, Dromer F, Dannaoui E, Carbon assimilation profiles as a tool for identification of zygomycetes, J. Clin. Microbiol. 2007 May;45(5):1433-9.
• 2007
  Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, , Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study, PLoS Med. 2007 Feb;4(2):e21.
• 2007
  Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Munoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S, , Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality, J. Infect. Dis. 2007 Mar;195(5):756-64.
• 2006
  Lasheras A, Rogues AM, Peyrere S, Boulard G, Bebear CM, Gachie JP, Bretagne S, Dromer F, Candida albicans outbreak in a neurosurgical intensive care unit, J. Hosp. Infect. 2007 Feb;65(2):181-2.
• 2006
  Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, Dellamonica P, Botterel F, Dromer F, Chêne G, Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy, AIDS 2006 Nov;20(17):2183-91.
• 2006
  Schwarz P, Janbon G, Dromer F, Lortholary O, Dannaoui E, Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans, Antimicrob. Agents Chemother. 2007 Jan;51(1):383-5.
• 2006
  Dannaoui E, Abdul M, Arpin M, Michel-Nguyen A, Piens MA, Favel A, Lortholary O, Dromer F, , Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis, Antimicrob. Agents Chemother. 2006 Jul;50(7):2464-70.
• 2006
  Bovers M, Hagen F, Kuramae EE, Diaz MR, Spanjaard L, Dromer F, Hoogveld HL, Boekhout T, Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii, FEMS Yeast Res. 2006 Jun;6(4):599-607.
• 2006
  Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, Dannaoui E, Molecular identification of zygomycetes from culture and experimentally infected tissues, J. Clin. Microbiol. 2006 Feb;44(2):340-9.
• 2006
  Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O, Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?, J. Antimicrob. Chemother. 2006 Mar;57(3):384-410.
• 2006
  Schwarz P, Dromer F, Lortholary O, Dannaoui E, Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis, Antimicrob. Agents Chemother. 2006 Jan;50(1):113-20.
• 2006
  Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel F, Huerre M, Dromer F, Dupont B, Lortholary O, Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis, AIDS 2006 Jan;20(1):119-21.
• 2005
  Cornet M, Bidard F, Schwarz P, Da Costa G, Blanchin-Roland S, Dromer F, Gaillardin C, Deletions of endocytic components VPS28 and VPS32 affect growth at alkaline pH and virulence through both RIM101-dependent and RIM101-independent pathways in Candida albicans, Infect. Immun. 2005 Dec;73(12):7977-87.
• 2005
  Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P, Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis, J. Clin. Microbiol. 2005 Sep;43(9):4902-4.
• 2005
  Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F,, Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France, AIDS 2005 Jul;19(10):1043-9.
• 2005
  Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F, Bonnin A, Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan, J. Clin. Microbiol. 2005 Jun;43(6):2929-31.
• 2005
  Lortholary O, Sitbon K, Dromer F,, Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis, Clin. Microbiol. Infect. 2005 Apr;11(4):296-300.
• 2005
  Iraqui I, Garcia-Sanchez S, Aubert S, Dromer F, Ghigo JM, d'Enfert C, Janbon G, The Yak1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway, Mol. Microbiol. 2005 Feb;55(4):1259-71.
• 2005
  Charlier C, Chrétien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F, Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier, Am. J. Pathol. 2005 Feb;166(2):421-32.
• 2004
  Garcia-Hermoso D, Dromer F, Janbon G, Cryptococcus neoformans capsule structure evolution in vitro and during murine infection, Infect. Immun. 2004 Jun;72(6):3359-65.
• 2004
  Lortholary O, Nunez H, Brauner MW, Dromer F, Pulmonary cryptococcosis, Semin Respir Crit Care Med 2004 Apr;25(2):145-57.
• 2004
  Dannaoui E, Lortholary O, Dromer F, In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus, Antimicrob. Agents Chemother. 2004 Mar;48(3):970-8.
• 2004
  Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O, , Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras, AIDS 2004 Feb;18(3):555-62.
• 2003
  Schwarz P, Dromer F, Lortholary O, Dannaoui E, In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates, Antimicrob. Agents Chemother. 2003 Oct;47(10):3361-4.
• 2003
  Cuenca-Estrella M, Moore CB, Barchiesi F, Bille J, Chryssanthou E, Denning DW, Donnelly JP, Dromer F, Dupont B, Rex JH, Richardson MD, Sancak B, Verweij PE, Rodríguez-Tudela JL, , Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST), Clin. Microbiol. Infect. 2003 Jun;9(6):467-74.
• 2003
  Kozel TR, Levitz SM, Dromer F, Gates MA, Thorkildson P, Janbon G, Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains, Infect. Immun. 2003 May;71(5):2868-75.
• 2003
  Imbert F, Jardin M, Fernandez C, Gantier JC, Dromer F, Baron G, Mentre F, Van Beijsterveldt L, Singlas E, Gimenez F, Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans, Drug Metab. Dispos. 2003 Mar;31(3):319-25.
• 2003
  Salomon J, Flament Saillour M, De Truchis P, Bougnoux ME, Dromer F, Dupont B, de Saint-Hardouin G, Perronne C, An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West Indies, J Travel Med 2003 Mar-Apr;10(2):87-93.
• 2003
  Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O, , Primary cutaneous cryptococcosis: a distinct clinical entity, Clin. Infect. Dis. 2003 Feb;36(3):337-47.
• 2002
  Dromer F, Chevalier R, Sendid B, Improvisi L, Jouault T, Robert R, Mallet JM, Poulain D, Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans, Antimicrob. Agents Chemother. 2002 Dec;46(12):3869-76.
• 2002
  Heymann P, Gerads M, Schaller M, Dromer F, Winkelmann G, Ernst JF, The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion, Infect. Immun. 2002 Sep;70(9):5246-55.
• 2002
  Chrétien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F, Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia, J. Infect. Dis. 2002 Aug;186(4):522-30.
• 2002
  Moyrand F, Klaproth B, Himmelreich U, Dromer F, Janbon G, Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans, Mol. Microbiol. 2002 Aug;45(3):837-49.
• 2002
  Richard M, Ibata-Ombetta S, Dromer F, Bordon-Pallier F, Jouault T, Gaillardin C, Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence and resistance to macrophages, Mol. Microbiol. 2002 May;44(3):841-53.
• 2002
  Karstaedt AS, Crewe-Brown HH, Dromer F, Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa, Med. Mycol. 2002 Feb;40(1):7-11.
• 2002
  Lortholary O, Improvisi L, Fitting C, Cavaillon JM, Dromer F, Influence of gender and age on course of infection and cytokine responses in mice with disseminated Cryptococcus neoformans infection, Clin. Microbiol. Infect. 2002 Jan;8(1):31-7.
• 2001
  Janbon G, Himmelreich U, Moyrand F, Improvisi L, Dromer F, Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide, Mol. Microbiol. 2001 Oct;42(2):453-67.
• 2001
  Boekhout T, Theelen B, Diaz M, Fell JW, Hop WC, Abeln EC, Dromer F, Meyer W, Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans, Microbiology (Reading, Engl.) 2001 Apr;147(Pt 4):891-907.
• 2001
  Garcia-Hermoso D, Dromer F, Mathoulin-Pelissier S, Janbon G, Are two Cryptococcus neoformans strains epidemiologically linked?, J. Clin. Microbiol. 2001 Apr;39(4):1402-6.
• 2001
  Nail S, Robert R, Dromer F, Marot-Leblond A, Senet JM, Susceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro, Infect. Immun. 2001 Feb;69(2):1221-5.
• 2000
  Lortholary O, Dromer F, Mathoulin-Pélissier S, Fitting C, Improvisi L, Cavaillon JM, Dupont B, , Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus, J. Infect. Dis. 2001 Jan;183(2):294-302.
• 2000
  Rayhane N, Fitting C, Lortholary O, Dromer F, Cavaillon JM, Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection, Infect. Immun. 2000 Jun;68(6):3748-53.
• 2000
  Neuville S, Lortholary O, Dromer F, Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?, Infect. Immun. 2000 Jun;68(6):3724-6.
• 2000
  Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM, Cryptococcosis: clinical and biological aspects, Med. Mycol. 2000;38 Suppl 1:205-13.
• 1999
  Lortholary O, Improvisi L, Rayhane N, Gray F, Fitting C, Cavaillon JM, Dromer F, Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection, Infect. Immun. 1999 Dec;67(12):6314-20.
• 1999
  Rayhane N, Lortholary O, Fitting C, Callebert J, Huerre M, Dromer F, Cavaillon JM, Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12, J. Infect. Dis. 1999 Nov;180(5):1637-47.
• 1999
  Garcia-Hermoso D, Janbon G, Dromer F, Epidemiological evidence for dormant Cryptococcus neoformans infection, J. Clin. Microbiol. 1999 Oct;37(10):3204-9.
• 1999
  Lortholary O, Improvisi L, Nicolas M, Provost F, Dupont B, Dromer F, Fungemia during murine cryptococcosis sheds some light on pathophysiology, Med. Mycol. 1999 Jun;37(3):169-74.
• 1999
  Lortholary O, Nicolas M, Soreda S, Improvisi L, Ronin O, Petitjean O, Dupont B, Tod M, Dromer F, Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timing, J. Antimicrob. Chemother. 1999 Jun;43(6):817-24.
• 1998
  Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D, Antifungal drug resistance in pathogenic fungi, Med. Mycol. 1998;36 Suppl 1:119-28.
• 1997
  Garcia-Hermoso D, Mathoulin-Pélissier S, Couprie B, Ronin O, Dupont B, Dromer F, DNA typing suggests pigeon droppings as a source of pathogenic Cryptococcus neoformans serotype D, J. Clin. Microbiol. 1997 Oct;35(10):2683-5.
• 1997
  Dromer F, Improvisi L, Dupont B, Eliaszewicz M, Pialoux G, Fournier S, Feuillie V, Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates, AIDS 1997 Jul;11(9):1095-101.
• 1996
  Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O, Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group, Clin. Infect. Dis. 1996 Jul;23(1):91-6.
• 1996
  Dromer F, Mathoulin S, Dupont B, Laporte A, Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group, Clin. Infect. Dis. 1996 Jul;23(1):82-90.
• 1996
  Dromer F, Mathoulin S, Dupont B, Brugiere O, Letenneur L, Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group, Clin. Infect. Dis. 1996 May;22 Suppl 2:S154-60.
• 1995
  Bart-Delabesse E, van Deventer H, Goessens W, Poirot JL, Lioret N, van Belkum A, Dromer F, Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unit, J. Clin. Microbiol. 1995 Dec;33(12):3278-83.
• 1995
  Gautheret A, Dromer F, Bourhis JH, Andremont A, Trichoderma pseudokoningii as a cause of fatal infection in a bone marrow transplant recipient, Clin. Infect. Dis. 1995 Apr;20(4):1063-4.
• 1995
  Dromer F, Moulignier A, Dupont B, Guého E, Baudrimont M, Improvisi L, Provost F, Gonzalez-Canali G, Myeloradiculitis due to Cryptococcus curvatus in AIDS, AIDS 1995 Apr;9(4):395-6.
• 1995
  Garcia-Hermoso D, Dromer F, Improvisi L, Provost F, Dupont B, Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole, Antimicrob. Agents Chemother. 1995 Mar;39(3):656-60.
• 1994
  Dromer F, Varma A, Ronin O, Mathoulin S, Dupont B, Molecular typing of Cryptococcus neoformans serotype D clinical isolates, J. Clin. Microbiol. 1994 Oct;32(10):2364-71.
• 1994
  Casadevall A, DeShaw M, Fan M, Dromer F, Kozel TR, Pirofski LA, Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan, Infect. Immun. 1994 Sep;62(9):3864-72.
• 1993
  Dromer F, Gueho E, Ronin O, Dupont B, Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide, J. Clin. Microbiol. 1993 Feb;31(2):359-63.
• 1992
  Kwon-Chung KJ, Kozel TR, Edman JC, Polacheck I, Ellis D, Shinoda T, Dromer F, Recent advances in biology and immunology of Cryptococcus neoformans, J. Med. Vet. Mycol. 1992;30 Suppl 1:133-42.
• 1992
  Dromer F, Ronin O, Dupont B, Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects, J. Med. Vet. Mycol. 1992;30(5):395-7.
• 1991
  Dromer F, Charreire J, Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: study during murine cryptococcosis and mechanisms of action, J. Infect. Dis. 1991 May;163(5):1114-20.
• 1990
  Dromer F, Barbet J, Bolard J, Charreire J, Yeni P, Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes, Antimicrob. Agents Chemother. 1990 Nov;34(11):2055-60.
• 1989
  Dromer F, Perronne C, Barge J, Vilde JL, Yeni P, Role of IgG and complement component C5 in the initial course of experimental cryptococcosis, Clin. Exp. Immunol. 1989 Dec;78(3):412-7.
• 1988
  Dromer F, Aucouturier P, Clauvel JP, Saimot G, Yeni P, Cryptococcus neoformans antibody levels in patients with AIDS, Scand. J. Infect. Dis. 1988;20(3):283-5.
• 1988
  Dromer F, Yeni P, Charreire J, Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice, Immunogenetics 1988;28(6):417-24.
• 1987
  Dromer F, Charreire J, Contrepois A, Carbon C, Yeni P, Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody, Infect. Immun. 1987 Mar;55(3):749-52.
• 1987
  Dromer F, Salamero J, Contrepois A, Carbon C, Yeni P, Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide, Infect. Immun. 1987 Mar;55(3):742-8.